These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 17339003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 6. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 7. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 8. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN, Piechota WT, Bejm J, Wierzbowski R, Michałkiewicz D.
    Adv Med Sci; 2006 Mar 20; 51():164-7. PubMed ID: 17357300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN, Val-HeFT Investigators.
    J Am Coll Cardiol; 2008 Sep 16; 52(12):997-1003. PubMed ID: 18786480
    [Abstract] [Full Text] [Related]

  • 14. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
    Alehagen U, Goetze JP, Dahlström U.
    Clin Chim Acta; 2007 Jul 16; 382(1-2):8-14. PubMed ID: 17433809
    [Abstract] [Full Text] [Related]

  • 15. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL, Chen-Tournoux AA, Moe G.
    Am J Cardiol; 2008 Feb 04; 101(3A):29-38. PubMed ID: 18243855
    [Abstract] [Full Text] [Related]

  • 16. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.
    Araújo JP, Azevedo A, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Am J Cardiol; 2006 Nov 01; 98(9):1248-50. PubMed ID: 17056340
    [Abstract] [Full Text] [Related]

  • 17. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM, Rauh M, Zink S, Singer H.
    Acta Paediatr; 2006 Jul 12; 95(7):805-9. PubMed ID: 16801175
    [Abstract] [Full Text] [Related]

  • 20. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A, Rehman SU, Mohammed A, Baggish AL, Moore SA, Januzzi JL.
    Am Heart J; 2010 Apr 12; 159(4):532-538.e1. PubMed ID: 20362709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.